Pharvaris
Price & Volume
Stats
See more52W Range | $15.37-$33 |
Market Cap | $1B |
Shares Short | 202,153 |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$2.73 |
News
See moreYahoo Finance • last year
Pharvaris to Present at the GA²LEN UCARE Conference 2023
Yahoo Finance • last year
Pharvaris Appoints Stefan Abele, Ph.D., as Chief Technical Operations Officer
Yahoo Finance • last year
Pharvaris Presents Deucrictibant Clinical Data and Real-World HAE Treatment Satisfaction Data at ACAAI 2023 Annual Scientific Meeting
Yahoo Finance • last year
Pharvaris Reports Third Quarter 2023 Financial Results and Provides Business Update
About
CEO | Mr. Berndt Axel Edvard Modig CPA, M.B.A. |
CFO | Mr. David W. Nassif J.D. |
Address | Emmy Noetherweg 2, Leiden, Netherlands, 2333 BK |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 83 |
